# Processa Pharmaceuticals, Inc.: Form DEF 14A, filed Oct 22, 2026

- Company: [Processa Pharmaceuticals, Inc.](/companies/pcsa.md) (CIK 1533743)
- Form: DEF 14A
- Filed: 2026-10-22
- Accepted by EDGAR: Oct 22, 2026, 16:37 ET
- Period: 2026-11-30
- Accession: 0001140361-26-040520
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1533743/000114036126040520/ny20083166x3_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1533743/000114036126040520/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1533743/000114036126040520/ny20083166x3_def14a.htm

Filed Oct 22, 2026.
Source: SEC EDGAR, the filing index for accession 0001140361-26-040520. Last ingested by Listed: Nov 5, 2026, 12:19 ET. No prices; not investment advice.